Intrinsiqs

Is IDEXX Laboratories, Inc. overvalued?

IDEXX Laboratories, Inc. (IDXX) looks overvalued — trading about 32% above its fair value.

Overvalued
Current price $551.50 Fair value $374.64
Price
$551.50
Fair value
$374.64
Current P/E
42.2
Normal P/E
28.6
Market cap
$43.50B
Dividend yield
0.0%
Return on equity
66.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares IDXX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.AMGN Amgen Inc.